The use of darunavir/ritonavir as intensification in low viremic HIV-infected patients treated with boosted protease inhibitor-containing regimens.
Sayana
Shilpa
S
Hamwi
Gerald
G
DenOuden
Paul
P
Easley
Ann
A
Khanlou
Homayoon
H
D000328:Adult; D000069454:Darunavir; D004359:Drug Therapy, Combination; D005260:Female; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000187:drug effects; D012313:RNA; D019438:Ritonavir / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D019562:Viral Load; D014766:Viremia / Q000188:drug therapy*
D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D012313:RNA; D019438:Ritonavir; D000069454:Darunavir